Bladder cancer
193 results
1 - 100
Bladder cancer - Bladder cancer (ultrasonography) - Image
- Adjuvant chemotherapy for invasive bladder cancer
Neo‐adjuvant chemotherapy for invasive bladder cancer- Neoadjuvant chemotherapy for invasive bladder cancer
Pioglitazone exposure increases bladder cancer risk- Bladder cancer screening: insufficient evidence to recommend (USPSTF)
- Surgery versus radiotherapy for muscle invasive bladder cancer
- Surgery versus radiotherapy for muscle invasive bladder cancer
- Neoadjuvant cisplatin for advanced bladder cancer: Cochrane systematic review
- Intravesical Bacillus Calmette‐Guérin in Ta and T1 bladder cancer
- Adjuvant chemotherapy for invasive bladder cancer (individual patient data)
- Selenium not helpful for patients with bladder cancer; vitamin E may be harmful
- Intravesical Bacillus Calmette‐Guérin versus epirubicin for Ta and T1 bladder cancer
- Perioperative nutrition for the treatment of bladder cancer by radical cystectomy
- En‐bloc resection versus conventional transurethral resection for patients with non‐muscle‐invasive bladder cancer
- Blue versus white light for transurethral resection of non‐muscle invasive bladder cancer
- Intravesical bacillus Calmette-Guerin versus mitomycin C for bladder cancer.
- Intravesical gemcitabine for non‐muscle invasive bladder cancer
- Intravesical Bacillus Calmette‐Guérin versus mitomycin C for Ta and T1 bladder cancer
- Gemcitabine for unresectable, locally advanced or metastatic bladder cancer: Cochrane systematic review
- Intravesical electromotive drug administration for non‐muscle invasive bladder cancer
- Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage cervical cancer
- Robotic versus open radical cystectomy for bladder cancer in adults
- Narrow band imaging versus white light cystoscopy alone for transurethral resection of non‐muscle invasive bladder cancer
- Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Cochrane systematic review
- Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for treating non‐muscle‐invasive bladder cancer
- Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy
- Single‐dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma
- Immunotherapy for advanced or metastatic urothelial carcinoma
- Benign prostatic hyperplasia
- Non‐surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis
- Urinary frequency (pollakiuria) and nocturia